| Brian H Windle, MD | |
|
7630 115th Pl Ne, Kirkland, WA 98033-6737 | |
| (425) 231-6156 | |
| Not Available |
| Full Name | Brian H Windle |
|---|---|
| Gender | Male |
| Speciality | Surgery - Plastic And Reconstructive Surgery |
| Location | 7630 115th Pl Ne, Kirkland, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972694743 | NPI | - | NPPES |
| 8322463 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | MD00041621 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brian H Windle, MD 7630 115th Pl Ne, Kirkland, WA 98033-6737 Ph: (425) 231-6156 | Brian H Windle, MD 7630 115th Pl Ne, Kirkland, WA 98033-6737 Ph: (425) 231-6156 |
News Archive
Researchers at the Children's Hospital of Philadelphia's Center for Injury Research and Prevention studied nearly 1,000 1- to 8-year-old children involved in crashes and found no evidence of increased injury risk for children across a broad weight range. All of the children included in the study were properly restrained in the correct child safety seat or booster seat for their height and weight.
The United States may be losing ground as the leader in biomedical research and within the next five years will be second to China in the funds it spends for R&D, according to Francis Collins, M.D., Ph.D, director of the National Institutes of Health.
Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that data from a phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia (hoFH) were published in The Lancet. This study met its primary endpoint, resulting in an average LDL-C reduction of greater than 100 mg/dL in this very high-risk patient population.
Onyx Pharmaceuticals, Inc. today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.
ulrich medical USA, Inc. today announced the release of two important product line enhancements to their growing spinal implant portfolio of expandable cage technologies.
› Verified 4 days ago
Dr. Michael A Towbin, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 12333 Ne 130th Ln, Suite 420, Kirkland, WA 98034 Phone: 425-899-5500 Fax: 425-899-5529 | |
John Dockins, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Ln Ste 400, Kirkland, WA 98034 Phone: 425-544-2000 | |
Dr. Iradj George Aflatooni, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 6511 Ne 138th Pl, Kirkland, WA 98034 Phone: 425-898-4796 Fax: 425-898-4796 | |
Andrew D Ludwig, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Ln Ste Tan 420, Kirkland, WA 98034 Phone: 258-995-5000 | |
Dr. Braden Charles Stridde, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 10117 Ne 58th Street, Suite 100, Kirkland, WA 98033 Phone: 425-202-4709 Fax: 425-576-4102 | |
Dr. Thomas D Gant, MD Surgery Medicare: Medicare Enrolled Practice Location: 9006 Ne 116th Pl, Kirkland, WA 98034 Phone: 206-999-0293 | |
Dr. James G. Mhyre, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 12333 Ne 130th Ln, Suite 420, Kirkland, WA 98034 Phone: 425-899-5500 Fax: 425-899-5529 |